20 participants
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-08
- Start Date:
- 2023-09-01
- Completion:
- 2029-09-30
Conditions
- Lymphoma
Interventions
- DRUG
No Results Yet